Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with Deep TMS

BACKGROUND: Major depressive disorder (MDD) can benefit from novel interventions and personalization. Deep transcranial magnetic stimulation (Deep TMS) targeting the lateral prefrontal cortex (LPFC) using the H1 coil was FDA cleared for treatment of MDD. However, recent preliminary data indicate tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zangen, Abraham, Zibman, Samuel, Tendler, Aron, Barnea-Ygael, Noam, Alyagon, Uri, Blumberger, Daniel M., Grammer, Geoffrey, Shalev, Hadar, Gulevski, Tatiana, Vapnik, Tanya, Bystritsky, Alexander, Filipčić, Igor, Feifel, David, Stein, Ahava, Deutsch, Frederic, Roth, Yiftach, George, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977507/
https://www.ncbi.nlm.nih.gov/pubmed/36692954
http://dx.doi.org/10.1172/jci.insight.165271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977507/
https://www.ncbi.nlm.nih.gov/pubmed/36692954
http://dx.doi.org/10.1172/jci.insight.165271

Ejemplares similares